Preparation of pharmaceutical compositions using supercycle vapor phase deposition of metal oxides
AssigneeApplied Materials, Inc.
InventorsMiaojun Wang, Kai Zheng, Lance A. Scudder, Sukti Chatterjee, Fei Wang, Shrikant Swaminathan, Pravin K. Narwankar
Life of this patent
Estimating the term…
Abstract
This disclosure pertains to methods to prepare coated particles comprising a drug-containing core and a coating of inorganic oxides applied by vapor phase deposition (supercycles). The coated particles have a modified drug release profile comparing to the uncoated drug particles.
Claims32
A method of preparing coated particles comprising drug-containing core enclosed by an inorganic oxide coating, wherein the drug-containing core comprises a drug, the method comprising the sequential steps of:
- (a) loading particles comprising a drug into a chamber of a reactor;
- (b) performing a first number of first cycles, wherein each first cycle comprises steps (b1)-(b4):
- (b1) applying a vaporous or gaseous first inorganic oxide precursor to the particles in the reactor by pulsing the vaporous or gaseous first inorganic oxide precursor into the reactor;
- (b2) purging using an inert gas or performing one or more pump-purge cycles of the reactor using an inert gas;
- (b3) applying a vaporous or gaseous oxidant to the particles in the reactor by pulsing the oxidant into the reactor;
- (b4) purging using an inert gas or performing one or more pump-purge cycles of the reactor using an inert gas;
- (c) performing a second number of second cycles, wherein each second cycle comprises steps (c1)-(c4):
- (c1) applying a vaporous or gaseous second inorganic oxide precursor to the particles in the reactor by pulsing the vaporous or gaseous second inorganic oxide precursor into the reactor;
- (c2) purging using an inert gas or performing one or more pump-purge cycles of the reactor using an inert gas;
- (c3) applying a vaporous or gaseous oxidant to the particles in the reactor by pulsing the oxidant into the reactor;
- (c4) purging using an inert gas or performing one or more pump-purge cycles of the reactor using an inert gas;
- and
- (d) repeating steps (b)-(c) at least once;
- wherein, the first inorganic oxide precursor and second inorganic oxide precursor are different;
- in each repeat of step (b) the first number is independently selected from 1-10 or 1-20;
- and in each repeat of step (c) the second number is independently selected from 1-10 or 1-20.
-5. (canceled)
-13. (canceled)
-17. (canceled)
-21. (canceled)
-26. (canceled)
-31. (canceled)
-36. (canceled)
(canceled)
A coated particle comprising drug-containing core enclosed by an inorganic oxide coating, wherein the drug-containing core comprises a drug, and the inorganic oxide coating comprising at least one layer composed of three elements (“three element inorganic oxide layer”), wherein the three elements are:
- a) aluminum, zinc and oxygen;
- b) aluminum, silicon and oxygen;
- or c) silicon, zinc and oxygen.
-48. (canceled)
-55. (canceled)
Dependencies are inferred from the claim text.